Peptide transporter substrate identification during permeability screening in drug discovery: Comparison of transfected MDCK-hPepT1 cells to Caco-2 cells

被引:17
作者
Balimane, Praveen. V.
Chong, Saeho
Patel, Karishma
Quan, Yong
Timoszyk, Julita
Han, Yong-Hae
Wang, Bonnie
Vig, Balvinder
Faria, Teresa N.
机构
[1] Bristol Myers Squibb Co, Metab & Pharmacokinet, Princeton, NJ 08543 USA
[2] Bristol Myers Squibb Co, Exploratory Biopharmaceut & Stabil, New Brunswick, NJ USA
关键词
hPepT1; MDCK cells; Caco-2; cells; high-throughput; P-gp; drug discovery; permeability; transporters;
D O I
10.1007/BF02980227
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The purpose of this study was to investigate the utility of stably transfected MDCK-hPepT1 cells for identifying peptide transporter substrates in early drug discovery and compare the characteristics of this cell line with Caco-2 cells. MDCK-hPepT1, MDCK-mock, and Caco-2 cells grown to confluence on 24-well Traanswell were used for this study. Expression levels of different transporter proteins (PepT1, PepT2, P-gp) in these cell lines were assessed by qRT-PCR. Permeability studies were conducted in parallel in all the cells with a diverse set of peptide substrates using the optimized experimental condition: 100 mu M, apical pH 6.0, basolateral pH 7.4, 2 hr incubation at 37 degrees C. Permeability studies were also conducted with classical P-gp substrates (tested in bi-directional mode) and paracellularly absorbed probes to investigate the differences between the cell lines. As expected, MDCK-hPepT1 cells express significantly higher level of PepT1 mRNA compared to both Caco-2 and MDCK-mock cells. Efflux transporter, P-gp, was expressed adequately in all the cell lines. Permeability studies demonstrated that classical peptide substrates had significantly higher permeability in stably transfected MDCK-hPepT1 cells compared to MDCK-mock and Caco-2 cells. The transfected MDCK-hPepT1 cells were qualitatively similar to Caco-2 cells with respect to functional P-gp efflux activity and paracellular pore activity. Stably transfected MDCK-hPepT1 cells have been demonstrated as a viable alternative to Caco-2 cells for estimating the human absorption potential of peptide transporter substrates. These cells behave similar to Caco-2 cells with regards to P-gp efflux and paracellular pore activity but demonstrate greater predictability of absorption values for classical peptide substrates (for which Caco-2 cells under-estimate oral absorption).
引用
收藏
页码:507 / 518
页数:12
相关论文
共 58 条
[21]   INTESTINAL-ABSORPTION MECHANISM OF DIPEPTIDE ANGIOTENSIN CONVERTING ENZYME-INHIBITORS OF THE LYSYL-PROLINE TYPE - LISINOPRIL AND SQ-29,852 [J].
FRIEDMAN, DI ;
AMIDON, GL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (12) :995-998
[22]  
Ganapathy V, 1996, Curr Opin Nephrol Hypertens, V5, P395, DOI 10.1097/00041552-199609000-00003
[23]  
Guo AL, 1999, J PHARMACOL EXP THER, V289, P448
[24]   Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter [J].
Han, HK ;
Oh, DM ;
Amidon, GL .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1382-1386
[25]   5′-amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter [J].
Han, HK ;
de Vrueh, RLA ;
Rhie, JK ;
Covitz, KMY ;
Smith, PL ;
Lee, CP ;
Oh, DM ;
Sadee, W ;
Amidon, GL .
PHARMACEUTICAL RESEARCH, 1998, 15 (08) :1154-1159
[26]   A novel hPepT1 stably transfected cell line: Establishing a correlation between expression and function [J].
Herrera-Ruiz, Dea ;
Faria, Teresa N. ;
Bhardwaj, Rajinder K. ;
Timoszyk, Julita ;
Gudmundsson, Olafur S. ;
Moench, Paul ;
Wall, Doris A. ;
Smith, Ronald L. ;
Knipp, Gregory T. .
MOLECULAR PHARMACEUTICS, 2004, 1 (02) :136-144
[27]  
Hidalgo Ismael J., 2001, Current Topics in Medicinal Chemistry, V1, P385, DOI 10.2174/1568026013395010
[28]   Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2 [J].
Ingels, FM ;
Augustijns, PF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (08) :1545-1558
[29]   Physiological and pharmacological implications of peptide transporters, PEPT1 and PEPT2 [J].
Inui, K ;
Terada, T ;
Masuda, S ;
Saito, H .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 :11-13
[30]   MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening [J].
Irvine, JD ;
Takahashi, L ;
Lockhart, K ;
Cheong, J ;
Tolan, JW ;
Selick, HE ;
Grove, JR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (01) :28-33